Hinge Health, INC Form 4 insider transactions

NYSE
Hinge Health's President, James Pursley, disposed of 5,126 Class A Common Stock shares to cover tax liabilities from restricted stock unit vesting.
NYSE
Bessemer Venture Partners, linked to Hinge Health Director Elliott Robinson, sold over 244,000 shares of Class A Common Stock in late November 2025.
NYSE
Hinge Health's Chief Financial Officer, James Budge, disposed of 8,213 Class A Common Stock shares at $48.91 each to cover tax liabilities from restricted stock unit vesting.
NYSE
Hinge Health's CFO, James Budge, sold 44,589 shares of Class A Common Stock on November 25, 2025, under a pre-arranged 10b5-1 trading plan.
NYSE
Hinge Health President James Pursley sold a total of 15,900 shares of Class A Common Stock on November 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Hinge Health Director Kristina M. Leslie reported a pre-planned sale of 1,250 shares of Class A Common Stock scheduled for November 21, 2025.
NYSE
Hinge Health's Chief Financial Officer, James Budge, sold 781 shares of Class A Common Stock for $44.78 per share under a pre-arranged trading plan.
NYSE
Bessemer Venture Partners, a 10% owner and director, converted Class B shares to Class A and subsequently sold 725,000 shares of Hinge Health, Inc. common stock for $40.05 per share.
NYSE
Bessemer Venture Partners, affiliated with Hinge Health Director Elliott Robinson, converted Class B to Class A shares and subsequently sold a portion of Class A common stock.
NYSE
Hinge Health Director Kristina M. Leslie reported sales of Class A Common Stock totaling 6,000 shares over two days.
NYSE
Hinge Health President James Pursley disposed of 15,977 Class A Common Stock shares to cover tax liabilities from restricted stock unit vesting.
NYSE
Hinge Health CFO James Budge disposed of 34,903 Class A Common Stock shares to cover tax liabilities from vested restricted stock units.
NYSE
Gabriel M.I. Mecklenburg, Executive Chairman and Co-Founder of Hinge Health, exercised stock options to acquire 326,807 shares of Class B Common Stock.
NYSE
Daniel Perez's spouse exercised stock options to acquire 35,470 shares of Hinge Health Class A Common Stock, with no shares sold.
NYSE
Bessemer Venture Partners, a 10% owner and director of Hinge Health, Inc. (HNGE), has reported the sale of 725,066 shares of Class A Common Stock for approximately $23.2 million following a conversion of preferred and Class B common stock.
NYSE
Atomico Advisors IV, Ltd., a 10% owner and director of Hinge Health, Inc., sold 2,651,103 shares of Class A Common Stock at $32 per share after converting them from Class B Common Stock.
NYSE
Insight Holdings Group, a significant shareholder and director of Hinge Health, Inc., reported the sale of 1,250,000 Class A Common Stock shares at $32.00 each, totaling $40 million, in connection with the issuer's initial public offering.
NYSE
11.2 Capital I Partners, LLC, a 10% owner and director of Hinge Health, Inc., reported the sale of 1,396,340 shares of Class A Common Stock for $32.00 per share, following the conversion of an equivalent number of Class B Common Stock shares.
NYSE
Hinge Health, Inc. Director Kristina M. Leslie reported a reclassification of 35,000 shares of Common Stock into Class A Common Stock, an exempt transaction related to the company's initial public offering.
NYSE
Hinge Health, Inc. Executive Chairman and Co-Founder Gabriel M.I. Mecklenburg reported significant changes in his beneficial ownership, including a reclassification of common stock into Class B shares and a disposal of shares for tax obligations.
NYSE
Hinge Health, Inc.'s Chief Financial Officer, James Budge, filed a Form 4 detailing an award of restricted stock units, a disposition of shares for tax liability, and a reclassification of common stock to Class A common stock.
NYSE
Hinge Health, Inc. President James Pursley reported the reclassification of 820,100 shares of Common Stock into Class A Common Stock and the award of 96,875 restricted stock units (RSUs) in recent SEC filings.
NYSE
Hinge Health, Inc. CEO and Co-Founder Daniel Antonio Perez filed a Form 4 detailing the reclassification of his and his spouse's common stock holdings into Class A and Class B shares, alongside a disposition of shares for tax obligations.